Atlas Trials

Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Cardiovascular Effects.

Clinical trial NCT05236335 · COMPLETED

Trial details

NCT number
NCT05236335
Sponsor
University of Aarhus
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Heart Failure With Preserved Ejection FractionDiabetes Mellitus, Type 2Ketonemia
Start date
2022-02-01
Primary completion
2023-06-15
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.